292 related articles for article (PubMed ID: 26779966)
1. Absence of Change in Corrected QT Interval in Children and Adolescents Receiving Antipsychotic Treatment: A 12 Month Study.
Alda JA; Muñoz-Samons D; Tor J; Merchán-Naranjo J; Tapia-Casellas C; Baeza I; Calvo-Escalona R; Castro-Fornieles J; Martínez-Cantarero C; Andrés-Nestares P; Fernández-Avilés F; Arango C
J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):449-57. PubMed ID: 26779966
[TBL] [Abstract][Full Text] [Related]
2. Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients.
Arango C; Giráldez M; Merchán-Naranjo J; Baeza I; Castro-Fornieles J; Alda JA; Martínez-Cantarero C; Moreno C; de Andrés P; Cuerda C; de la Serna E; Correll CU; Fraguas D; Parellada M
J Am Acad Child Adolesc Psychiatry; 2014 Nov; 53(11):1179-90,1190.e1-4. PubMed ID: 25440308
[TBL] [Abstract][Full Text] [Related]
3. Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
Carbon M; Kapoor S; Sheridan E; Al-Jadiri A; Azzo S; Sarkaria T; Kane JM; Saito E; Correll CU
J Am Acad Child Adolesc Psychiatry; 2015 Sep; 54(9):718-727.e3. PubMed ID: 26299293
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in the effect of four second-generation antipsychotics on QTc interval in patients with schizophrenia.
Suzuki Y; Sugai T; Fukui N; Watanabe J; Ono S; Tsuneyama N; Saito M; Someya T
Hum Psychopharmacol; 2013 May; 28(3):215-9. PubMed ID: 23553637
[TBL] [Abstract][Full Text] [Related]
5. Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth.
Al-Dhaher Z; Kapoor S; Saito E; Krakower S; David L; Ake T; Kane JM; Correll CU; Carbon M
J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):458-70. PubMed ID: 27093218
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
[TBL] [Abstract][Full Text] [Related]
7. QTc changes after 6 months of second-generation antipsychotic treatment in children and adolescents.
de Castro MJ; Fraguas D; Laita P; Moreno D; Parellada M; Pascual D; Alvarez M; Merchán-Naranjo J; Rapado M; Giráldez M; Leiva M; Arango C
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):381-3. PubMed ID: 18759648
[No Abstract] [Full Text] [Related]
8. Neurological Adverse Effects of Antipsychotics in Children and Adolescents.
Garcia-Amador M; Merchán-Naranjo J; Tapia C; Moreno C; Castro-Fornieles J; Baeza I; de la Serna E; Alda JA; Muñoz D; Andrés Nestares P; Cantarero CM; Arango C
J Clin Psychopharmacol; 2015 Dec; 35(6):686-93. PubMed ID: 26505569
[TBL] [Abstract][Full Text] [Related]
9. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.
Czekalla J; Beasley CM; Dellva MA; Berg PH; Grundy S
J Clin Psychiatry; 2001 Mar; 62(3):191-8. PubMed ID: 11305706
[TBL] [Abstract][Full Text] [Related]
11. A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.
Harrigan EP; Miceli JJ; Anziano R; Watsky E; Reeves KR; Cutler NR; Sramek J; Shiovitz T; Middle M
J Clin Psychopharmacol; 2004 Feb; 24(1):62-9. PubMed ID: 14709949
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Effects of Quetiapine on QTc Prolongation in Critically Ill Patients.
Dube KM; DeGrado J; Hohlfelder B; Szumita PM
J Pharm Pract; 2018 Jun; 31(3):292-297. PubMed ID: 28583014
[TBL] [Abstract][Full Text] [Related]
14. Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics.
Fraguas D; Merchán-Naranjo J; Laita P; Parellada M; Moreno D; Ruiz-Sancho A; Cifuentes A; Giráldez M; Arango C
J Clin Psychiatry; 2008 Jul; 69(7):1166-75. PubMed ID: 18588363
[TBL] [Abstract][Full Text] [Related]
15. Comparative cardiovascular safety of risperidone and olanzapine, based on electrocardiographic parameters and blood pressure: a prospective open label observational study.
Choure BK; Gosavi D; Nanotkar S
Indian J Pharmacol; 2014; 46(5):493-7. PubMed ID: 25298577
[TBL] [Abstract][Full Text] [Related]
16. Increased Risk of Obesity and Metabolic Dysregulation Following 12 Months of Second-Generation Antipsychotic Treatment in Children: A Prospective Cohort Study.
Ronsley R; Nguyen D; Davidson J; Panagiotopoulos C
Can J Psychiatry; 2015 Oct; 60(10):441-50. PubMed ID: 26720191
[TBL] [Abstract][Full Text] [Related]
17. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.
Layton D; Harris S; Wilton LV; Shakir SA
J Psychopharmacol; 2005 Sep; 19(5):473-82. PubMed ID: 16166184
[TBL] [Abstract][Full Text] [Related]
18. Corrected QT changes during antipsychotic treatment of children and adolescents: a systematic review and meta-analysis of clinical trials.
Jensen KG; Juul K; Fink-Jensen A; Correll CU; Pagsberg AK
J Am Acad Child Adolesc Psychiatry; 2015 Jan; 54(1):25-36. PubMed ID: 25524787
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.
Juncal-Ruiz M; Ramirez-Bonilla M; Gomez-Arnau J; Ortiz-Garcia de la Foz V; Suarez-Pinilla P; Martinez-Garcia O; Neergaard KD; Tabares-Seisdedos R; Crespo-Facorro B
Psychopharmacology (Berl); 2017 Sep; 234(17):2563-2570. PubMed ID: 28567698
[TBL] [Abstract][Full Text] [Related]
20. The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study.
Baeza I; Vigo L; de la Serna E; Calvo-Escalona R; Merchán-Naranjo J; Rodríguez-Latorre P; Arango C; Castro-Fornieles J
Eur Child Adolesc Psychiatry; 2017 Jan; 26(1):35-46. PubMed ID: 27209421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
